Similarly, Sun et al. (2020) discovered that Clostridium butyricum treatment ameliorated cognitive deficits and decreased Aβ oligomerization in APP/PS1 mice by reversing abnormal butyrate levels and gut microbiota alterations, which helped to suppress microglial activation. Here, APP is linked to Cognitive impairment.